Invasion and MMP Expression Profile in Desmoid Tumours

Overview

Journal Br J Cancer

Specialty Oncology

Date 2004 Apr 1

PMID 15054469

Citations 20

Authors

H Denys

O De Wever

B Nusgens

Y Kong

R Sciot

A-T Le

K van Dam

A Jadidizadeh

S Tejpar

M Mareel

B Alman

J-J Cassiman

Affiliations

Soon will be listed here.

Abstract

Desmoid tumours are locally invasive soft tissue tumours in which beta-catenin mediated TCF-dependent transcription is activated. The role of soluble factors secreted by the myofibroblastic desmoid tumour, which could stimulate tumour invasiveness, was investigated. Using collagen gel invasion assays, the presence of factors stimulating invasion in desmoid conditioned media (CM) could be established. Since matrix metalloproteinases (MMPs) have been implicated in the process of tumoral invasion, the expression levels of the MMP family members were evaluated. Quantitative reverse transcription-PCR was used to determine the expression levels of MMP1, MMP2, MMP3, MMP7, MMP11, MMP12, MMP13, MMP14 and the inhibitors TIMP1, TIMP2 and TIMP3. Besides overexpression of MMP7, a known TCF-dependent target gene, a striking upregulation of the expression levels of MMP1, MMP3, MMP11, MMP12 and MMP13 in desmoid tumours, compared to unaffected fibroblasts from the same patients, was found. Treating the CM of desmoids with a synthetic and a physiologic MMP inhibitor reduced the invasion-stimulating capacity of the desmoid CM by approximately 50%. These results suggest the involvement of soluble factors, released by the desmoid cells, in stimulating invasion and implicate the MMPs as facilitators of invasion.

Citing Articles

Short- and long-term polystyrene nano- and microplastic exposure promotes oxidative stress and divergently affects skin cell architecture and Wnt/beta-catenin signaling.

Schmidt A, da Silva Brito W, Singer D, Muhl M, Berner J, Saadati F Part Fibre Toxicol. 2023; 20(1):3.

PMID: 36647127 PMC: 9844005. DOI: 10.1186/s12989-023-00513-1.

Germline gain-of-function MMP11 variant results in an aggressive form of colorectal cancer.

Martin-Morales L, Manzano S, Rodrigo-Faus M, Vicente-Barrueco A, Lorca V, Nunez-Moreno G Int J Cancer. 2022; 152(2):283-297.

PMID: 36093604 PMC: 9827992. DOI: 10.1002/ijc.34289.

Molecular Pathogenesis of Sporadic Desmoid Tumours and Its Implications for Novel Therapies: A Systematised Narrative Review.

McLean T, Duchi S, Di Bella C Target Oncol. 2022; 17(3):223-252.

PMID: 35446005 PMC: 9217905. DOI: 10.1007/s11523-022-00876-z.

Preeclampsia-Associated lncRNA Regulates the Proliferation, Invasion, and Migration of Placental Trophoblast Cells.

Jiang S, Chen Q, Liu H, Gao Y, Yang X, Ren Z Mol Ther Nucleic Acids. 2020; 22:684-695.

PMID: 33230466 PMC: 7585871. DOI: 10.1016/j.omtn.2020.09.033.

Matrix Metalloproteinase 11 is a Potential Biomarker in Bladder Cancer Diagnosis and Prognosis.

Chen C, Liu X, Jiang J, Li S, Wang G, Ju L Onco Targets Ther. 2020; 13:9059-9069.

PMID: 32982295 PMC: 7494396. DOI: 10.2147/OTT.S243452.

References

Drewinko B, Romsdahl M, Yang L, Ahearn M, Trujillo J . Establishment of a human carcinoembryonic antigen-producing colon adenocarcinoma cell line. Cancer Res. 1976; 36(2 Pt 1):467-75. View

Marchenko G, Marchenko N, Leng J, Strongin A . Promoter characterization of the novel human matrix metalloproteinase-26 gene: regulation by the T-cell factor-4 implies specific expression of the gene in cancer cells of epithelial origin. Biochem J. 2002; 363(Pt 2):253-62. PMC: 1222473. DOI: 10.1042/0264-6021:3630253. View

Regnauld K, Nguyen Q, Vakaet L, Bruyneel E, Launay J, Endo T . G-protein alpha(olf) subunit promotes cellular invasion, survival, and neuroendocrine differentiation in digestive and urogenital epithelial cells. Oncogene. 2002; 21(25):4020-31. DOI: 10.1038/sj.onc.1205498. View

Nagashima Y, Hasegawa S, Koshikawa N, Taki A, Ichikawa Y, Kitamura H . Expression of matrilysin in vascular endothelial cells adjacent to matrilysin-producing tumors. Int J Cancer. 1997; 72(3):441-5. DOI: 10.1002/(sici)1097-0215(19970729)72:3<441::aid-ijc11>3.0.co;2-f. View

Tejpar S, Nollet F, Li C, Wunder J, Michils G, Dal Cin P . Predominance of beta-catenin mutations and beta-catenin dysregulation in sporadic aggressive fibromatosis (desmoid tumor). Oncogene. 1999; 18(47):6615-20. DOI: 10.1038/sj.onc.1203041. View

de Wever O, Mareel M . Role of myofibroblasts at the invasion front. Biol Chem. 2002; 383(1):55-67. DOI: 10.1515/BC.2002.006. View

Noel A, Albert V, Bajou K, Bisson C, Devy L, Frankenne F . New functions of stromal proteases and their inhibitors in tumor progression. Surg Oncol Clin N Am. 2001; 10(2):417-32, x-xi. View

Debruyne P, Bruyneel E, Li X, Flatau G, Muller O, Zimber A . Bile acids stimulate invasion and haptotaxis in human colorectal cancer cells through activation of multiple oncogenic signaling pathways. Oncogene. 2002; 21(44):6740-50. DOI: 10.1038/sj.onc.1205729. View

Gomez D, Alonso D, Yoshiji H, Thorgeirsson U . Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Eur J Cell Biol. 1997; 74(2):111-22. View

10.

Takahashi M, Tsunoda T, Seiki M, Nakamura Y, Furukawa Y . Identification of membrane-type matrix metalloproteinase-1 as a target of the beta-catenin/Tcf4 complex in human colorectal cancers. Oncogene. 2002; 21(38):5861-7. DOI: 10.1038/sj.onc.1205755. View

11.

Nusgens B, Humbert P, Rougier A, Colige A, Haftek M, Lambert C . Topically applied vitamin C enhances the mRNA level of collagens I and III, their processing enzymes and tissue inhibitor of matrix metalloproteinase 1 in the human dermis. J Invest Dermatol. 2001; 116(6):853-9. DOI: 10.1046/j.0022-202x.2001.01362.x. View

12.

Tejpar S, Li C, Yu C, Poon R, Denys H, Sciot R . Tcf-3 expression and beta-catenin mediated transcriptional activation in aggressive fibromatosis (desmoid tumour). Br J Cancer. 2001; 85(1):98-101. PMC: 2363921. DOI: 10.1054/bjoc.2001.1857. View

13.

DeClerck Y, Perez N, Shimada H, Boone T, Langley K, Taylor S . Inhibition of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases. Cancer Res. 1992; 52(3):701-8. View

14.

Crawford H, Matrisian L . Mechanisms controlling the transcription of matrix metalloproteinase genes in normal and neoplastic cells. Enzyme Protein. 1996; 49(1-3):20-37. DOI: 10.1159/000468614. View

15.

Nakayama H, Enzan H, Miyazaki E, Naruse K, Kiyoku H, Hiroi M . The role of myofibroblasts at the tumor border of invasive colorectal adenocarcinomas. Jpn J Clin Oncol. 1998; 28(10):615-20. DOI: 10.1093/jjco/28.10.615. View

16.

Curran S, Murray G . Matrix metalloproteinases in tumour invasion and metastasis. J Pathol. 1999; 189(3):300-8. DOI: 10.1002/(SICI)1096-9896(199911)189:3<300::AID-PATH456>3.0.CO;2-C. View

17.

Lewis J, Boland P, Leung D, Woodruff J, Brennan M . The enigma of desmoid tumors. Ann Surg. 1999; 229(6):866-72; discussion 872-3. PMC: 1420834. DOI: 10.1097/00000658-199906000-00014. View

18.

Tanaka K, Iwamoto Y, Ito Y, Ishibashi T, Nakabeppu Y, Sekiguchi M . Cyclic AMP-regulated synthesis of the tissue inhibitors of metalloproteinases suppresses the invasive potential of the human fibrosarcoma cell line HT1080. Cancer Res. 1995; 55(13):2927-35. View

19.

Vermeulen S, Bruyneel E, Bracke M, De Bruyne G, Vennekens K, Vleminckx K . Transition from the noninvasive to the invasive phenotype and loss of alpha-catenin in human colon cancer cells. Cancer Res. 1995; 55(20):4722-8. View

20.

Bracke M, Boterberg T, Bruyneel E, Mareel M . Collagen invasion assay. Methods Mol Med. 2011; 58:81-9. DOI: 10.1385/1-59259-137-X:081. View